1 min to read
Posted on

Ross Acquisition II Pushes for 6-Month Extension After APRINOIA Therapeutics Deal Collapse

Ross Acquisition II in a proxy filing seeks to extend its deal deadline to March 2024. The move follows the termination last week of a $320 million merger agreement with -based APRINOIA Therapeutics.

If the extension is approved, the new deadline will mark the three-year anniversary of the SPAC's IPO.

Ross II's cash in trust stands at about $65 million, down from the  $350.6 million the SPAC held when the APRINOIA deal was announced in January.

The SPAC was founded by Wilbur Ross, former commerce secretary during the Administration. Read more.


Source: Ross Acquisition II Pushes for 6-Month Extension After APRINOIA Therapeutics Deal Collapse

Tags: SPACs